Company intelligence / Profile preview

iMerciv

Toronto, Ontario, Canadaimerciv.com ↗

Ownership: Private
Development stage: Commercial

Overview

iMerciv develops and commercializes assistive vision technology tools designed to enhance mobility and independence for individuals with visual impairments. Their products are used post-LASIK or cataract surgery and for general low vision support.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on iMerciv.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iMerciv.

Explore the full profile